Found 24 clinical trials
Chemotherapy and G-CSF for Mobilization (MOCCCA)
This study aims to demonstrate that the mobilization with cytokine stimulation with G-CSF alone is non-inferior as compared to the standard mobilization with chemotherapy and G-CSF while associated with fewer side effects in myeloma patients.
- 4 views
- 26 Feb, 2022
- 1 location
Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- MBC
This is an open-label, randomized, multicenter Phase 3 study to compare the efficacy and safety of sacituzumab govitecan versus TPC in subjects with metastatic or locally recurrent inoperable HR+/HER2- MBC, after failure of at least 2, and no more than 4, prior chemotherapy regimens for metastatic disease.
- 7 views
- 02 May, 2022
- 39 locations
FUSCC Refractory TNBC Umbrella (FUTURE) (FUTURE)
This is a Phase Ib/II, open-label, multi-center umbrella study evaluating the efficacy and safety of multiple targeted treatment in patients with refractory metastatic TNBC.The specific grouping of patients' depends on FUSCC 500+ gene panel testing and IHC subtype staining.
- 24 views
- 18 Apr, 2022
- 1 location
Pharmacodynamic Biomarkers of Standard Anti-microtubule Drugs as Assessed by Early Tumor Biopsy
, Vinorelbine, Ixabepilone, or the control arm (non-microtubule targeted chemotherapies such as doxorubicin, carboplatin, or gemcitabine).
- 8 views
- 28 Feb, 2022
- 1 location